FreeTrader
عضو محترف
ولع في الافتر اورز
Healthways beats by $0.01; issues Q1 EPS in-line, mixed Y07 guidance (39.29 +0.15) : Reports Q4 (Aug) earnings of $0.38 per share, $0.01 better than the Reuters Estimates consensus of $0.37; revenues rose 31.2% year/year to $114.9 mln vs the $114.3 mln consensus. Co issues in-line guidance for Q1, sees EPS of $0.31-0.34 vs. $0.33 consensus. Co issues mixed guidance for FY07, sees EPS of $1.44-1.61 vs. $1.49 consensus; sees FY07 revs of $667-701 mln vs. $513.21 mln consensus
Healthways beats by $0.01; issues Q1 EPS in-line, mixed Y07 guidance (39.29 +0.15) : Reports Q4 (Aug) earnings of $0.38 per share, $0.01 better than the Reuters Estimates consensus of $0.37; revenues rose 31.2% year/year to $114.9 mln vs the $114.3 mln consensus. Co issues in-line guidance for Q1, sees EPS of $0.31-0.34 vs. $0.33 consensus. Co issues mixed guidance for FY07, sees EPS of $1.44-1.61 vs. $1.49 consensus; sees FY07 revs of $667-701 mln vs. $513.21 mln consensus